Thermo Fisher Scientific Award Recognizes Human Gut Mobile Metagenome Researcher

Thermo Fisher Scientific, the world leader in serving science, today announced that the 2011 Oxoid W H Pierce Memorial Prize, which commemorates the late W H (Bill) Pierce, has been awarded to Dr. Brian Jones, senior lecturer at the University of Brighton, England. The award acknowledges Dr. Jones’ research into the human gut mobile metagenome, the mobile genetic elements (such as plasmids) that are associated with gut microbiota.

Dr. Brian Jones, senior lecturer at the University of Brighton
Dr. Brian Jones, senior lecturer at the University of Brighton
Dr. Brian Jones, senior lecturer at the University of Brighton
Dr. Brian Jones, senior lecturer at the University of Brighton

Awarded under the auspices of the Society for Applied Microbiology (SfAM), the Oxoid W H Pierce Memorial Prize is presented every year to a young Society member who has made a substantial contribution to microbiology. Dr. Jones is developing methods to study the transfer of genetic material within the whole gastric microbial community. This work will shed valuable light on our understanding of what is happening in the human gut microbiota and how it is involved in various diseases.
Dr. Brian Jones graduated from the University of Cardiff in 2000 with a 1st Class Honours degree in Genetics and went on to complete his Ph.D on bacterial pathogenesis at the same university. He then spent four years in the Alimentary Pharmabiotic Centre at the University College of Cork in Ireland where he began the application of metagenomic approaches to understand the functioning of the human gut microbiota. It was at this time that he became interested in mobile genetic elements associated with this community and began to develop strategies to investigate the human gut mobile metagenome.
In 2008, Dr. Jones accepted a lectureship in the School of Pharmacy and Biomolecular Sciences at the University of Brighton, where he has established his own research group. His research continues to investigate the human gut mobile metagenome as well as the gut microbiota in general, with a major project currently underway aimed at understanding the role of gut bacteria in colon cancer.

“I’m delighted to be awarded this prize, but I can’t take all the credit,” said Dr. Jones. “I’ve been lucky enough to work with many excellent and supportive people over the last 10 years, most recently colleagues at the University of Brighton and my research group.”
For further information about the Oxoid W H Pierce Memorial Prize, please visit the SfAM website at www.sfam.org.uk.
Oxoid is a specialty microbiology brand of Thermo Fisher Scientific Inc., the world leader in serving science.
 

03.08.2011

More on the subject:More on companies:
Read all latest stories

Related articles

Photo

Sponsored • Addressing a broad range of research applications

Mass spectrometry advances

Since the Covid-19 epidemic took hold, the public has expected ‘unprecedented progress from the scientific community,’ observed Dan Shine, senior vice president and president of the analytical…

Photo

Sponsored • Liquid chromatography/mass spectrometry

LC-MS: Calling for easy-to-use platforms

Liquid chromatography/mass spectrometry (LC-MS) is an established powerful tool in routine clinical use and clinical research. However, to further capitalise on its benefits, instrument and…

Photo

Sponsored • Testing technology

Vitamin D testing: LC-MS outperforms immunoassays

In recent years, clinicians have increasingly focused on vitamin D deficiency. Studies show that previous reference values – particularly for Vitamin D3 – were most probably set too high. Liquid…

Related products

Subscribe to Newsletter